HHS Communications Regarding FDA Decision on Convalescent Plasma

Records from the U.S. Department of Health and Human Services in response to American Oversight’s request for FDA communications regarding Covid-19 treatments. These records include communication concerning the FDA’s decision to on convalescent plasma from August 2020.